Table 1 Metastatic patient characteristics
Characteristics | No. of patients | % |
---|---|---|
Entered on study | 59 | 100 |
Age (years) | ||
Median | 54 | |
Range | 26–83 | |
PS | ||
0–1 | 41 | 69.5 |
2–4 | 18 | 30.5 |
Receptor status (four missing values) | ||
ER positive | 39 | 71 |
ER negative | 16 | 29 |
Adjuvant chemotherapy | ||
Received | 28 | 47.5 |
Not received | 31 | 52.5 |
Prior chemotherapy for metastatic disease | ||
Received | 41 | 69.5 |
Not received | 18 | 30.5 |
Disease-free interval (months) | ||
<24 | 27 | 46 |
>24 | 32 | 54 |
Metastatic site | ||
Liver | 36 | 61 |
Lung | 27 | 46 |
One or two | 34 | 58 |
Three or more | 25 | 42 |
Lymphocyte count (106 cells l−1) | ||
Median | 905 | |
Range | 100–2700 |